Shares of Verici Dx plc (LON:VRCI – Get Free Report) traded up 31.8% during mid-day trading on Thursday . The stock traded as high as GBX 3.63 ($0.05) and last traded at GBX 3.63 ($0.05). 959,982 shares changed hands during mid-day trading, an increase of 65% from the average session volume of 581,209 shares. The stock had previously closed at GBX 2.75 ($0.04).
Verici Dx Price Performance
The company has a current ratio of 4.54, a quick ratio of 8.49 and a debt-to-equity ratio of 4.64. The stock has a market cap of £8.62 million, a PE ratio of -1.65 and a beta of 1.59. The company has a fifty day moving average of GBX 3.77 and a 200-day moving average of GBX 4.33.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Read More
- Five stocks we like better than Verici Dx
- What Does Downgrade Mean in Investing?
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- What Does a Stock Split Mean?
- 3 Stocks to Buy While Others Stay on the Sidelines
- 3 Small Caps With Big Return Potential
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
